Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy.

Flores C, Wildes T, Dean BD, Moore G, Drake J, Abraham R, Gil J, Yegorov O, Yang C, Dean J, Moneypenny C, Shin D, Pham C, Krauser J, King J, Grant G, Driscoll T, Kurtzberg J, McLendon R, Gururangan S, Mitchell D.

Sci Adv. 2019 Nov 27;5(11):eaav9879. doi: 10.1126/sciadv.aav9879. eCollection 2019 Nov.

2.

Best practices for the use of intracerebroventricular drug delivery devices.

Slavc I, Cohen-Pfeffer JL, Gururangan S, Krauser J, Lim DA, Maldaun M, Schwering C, Shaywitz AJ, Westphal M.

Mol Genet Metab. 2018 Jul;124(3):184-188. doi: 10.1016/j.ymgme.2018.05.003. Epub 2018 May 16.

3.

Investigation of Feshbach resonances in ultracold 40K spin mixtures.

Krauser JS, Heinze J, Götze S, Langbecker M, Fläschner N, Cook L, Hanna TM, Tiesinga E, Sengstock K, Becker C.

Phys Rev A (Coll Park). 2017 Apr;95(4). pii: 042701. doi: 10.1103/PhysRevA.95.042701. Epub 2017 Apr 3.

4.

ADME studies of [5-(3)H]-2'-O-methyluridine nucleoside in mice: a building block in siRNA therapeutics.

Lozac'h F, Christensen J, Faller T, van de Kerkhof E, Krauser J, Garnier M, Litherland K, Catoire A, Natt F, Hunziker J, Swart P.

Pharmacol Res Perspect. 2016 Feb 1;4(1):e00209. doi: 10.1002/prp2.209. eCollection 2016 Feb.

5.

MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod).

Briard E, Rudolph B, Desrayaud S, Krauser JA, Auberson YP.

ChemMedChem. 2015 Jun;10(6):1008-18. doi: 10.1002/cmdc.201500115. Epub 2015 Apr 29.

PMID:
25924727
6.

Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite.

Krauser JA, Jin Y, Walles M, Pfaar U, Sutton J, Wiesmann M, Graf D, Pflimlin-Fritschy V, Wolf T, Camenisch G, Swart P.

Xenobiotica. 2015 Feb;45(2):107-23. doi: 10.3109/00498254.2014.945988. Epub 2014 Sep 2.

PMID:
25180976
7.

Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist.

Stringer RA, Williams G, Picard F, Sohal B, Kretz O, McKenna J, Krauser JA.

Drug Metab Dispos. 2014 May;42(5):954-62. doi: 10.1124/dmd.114.057265. Epub 2014 Mar 10.

PMID:
24616265
8.

Giant spin oscillations in an ultracold Fermi sea.

Krauser JS, Ebling U, Fläschner N, Heinze J, Sengstock K, Lewenstein M, Eckardt A, Becker C.

Science. 2014 Jan 10;343(6167):157-60. doi: 10.1126/science.1244059.

PMID:
24408429
9.

Biodistribution and metabolism studies of lipid nanoparticle-formulated internally [3H]-labeled siRNA in mice.

Christensen J, Litherland K, Faller T, van de Kerkhof E, Natt F, Hunziker J, Boos J, Beuvink I, Bowman K, Baryza J, Beverly M, Vargeese C, Heudi O, Stoeckli M, Krauser J, Swart P.

Drug Metab Dispos. 2014 Mar;42(3):431-40. doi: 10.1124/dmd.113.055434. Epub 2014 Jan 3.

PMID:
24389421
10.

A perspective on tritium versus carbon-14: ensuring optimal label selection in pharmaceutical research and development.

Krauser JA.

J Labelled Comp Radiopharm. 2013 Jul-Aug;56(9-10):441-6. doi: 10.1002/jlcr.3085. Epub 2013 Jul 23.

PMID:
24285517
11.

Engineering spin waves in a high-spin ultracold Fermi gas.

Heinze J, Krauser JS, Fläschner N, Sengstock K, Becker C, Ebling U, Eckardt A, Lewenstein M.

Phys Rev Lett. 2013 Jun 21;110(25):250402. Epub 2013 Jun 19.

PMID:
23829716
12.

Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects.

Walles M, Wolf T, Jin Y, Ritzau M, Leuthold LA, Krauser J, Gschwind HP, Carcache D, Kittelmann M, Ocwieja M, Ufer M, Woessner R, Chakraborty A, Swart P.

Drug Metab Dispos. 2013 Sep;41(9):1626-41. doi: 10.1124/dmd.112.050716. Epub 2013 Jun 17.

PMID:
23775850
13.

Metabolism studies of unformulated internally [3H]-labeled short interfering RNAs in mice.

Christensen J, Litherland K, Faller T, van de Kerkhof E, Natt F, Hunziker J, Krauser J, Swart P.

Drug Metab Dispos. 2013 Jun;41(6):1211-9. doi: 10.1124/dmd.112.050666. Epub 2013 Mar 22.

PMID:
23524663
14.

Intrinsic photoconductivity of ultracold fermions in optical lattices.

Heinze J, Krauser JS, Fläschner N, Hundt B, Götze S, Itin AP, Mathey L, Sengstock K, Becker C.

Phys Rev Lett. 2013 Feb 22;110(8):085302. Epub 2013 Feb 19.

PMID:
23473159
15.

A unique automation platform for measuring low level radioactivity in metabolite identification studies.

Krauser J, Walles M, Wolf T, Graf D, Swart P.

PLoS One. 2012;7(6):e39070. doi: 10.1371/journal.pone.0039070. Epub 2012 Jun 18.

16.

Multiband spectroscopy of ultracold fermions: observation of reduced tunneling in attractive Bose-Fermi mixtures.

Heinze J, Götze S, Krauser JS, Hundt B, Fläschner N, Lühmann DS, Becker C, Sengstock K.

Phys Rev Lett. 2011 Sep 23;107(13):135303. Epub 2011 Sep 23.

PMID:
22026869
17.

Detecting the amplitude mode of strongly interacting lattice bosons by Bragg scattering.

Bissbort U, Götze S, Li Y, Heinze J, Krauser JS, Weinberg M, Becker C, Sengstock K, Hofstetter W.

Phys Rev Lett. 2011 May 20;106(20):205303. Epub 2011 May 20.

PMID:
21668240
18.

Evaluation of an anorganic bovine-derived mineral with P-15 hydrogel bone graft: preliminary study in a rabbit cranial bone model.

Matos S, Guerra F, Krauser JT, Figueiredo H, Marcelino JP, Sanz M.

Clin Oral Implants Res. 2012 Jun;23(6):698-705. doi: 10.1111/j.1600-0501.2011.02179.x. Epub 2011 Apr 19.

PMID:
21504482
19.

Small peptide (P-15) bone substitute efficacy in a rabbit cancellous bone model.

Lindley EM, Guerra FA, Krauser JT, Matos SM, Burger EL, Patel VV.

J Biomed Mater Res B Appl Biomater. 2010 Aug;94(2):463-8. doi: 10.1002/jbm.b.31676.

PMID:
20578227
20.

Metal complexes of modified cyclen as catalysts for hydrolytic restriction of plasmid DNA.

Krauser JA, Joshi AL, Kady IO.

J Inorg Biochem. 2010 Aug;104(8):877-84. doi: 10.1016/j.jinorgbio.2010.04.007. Epub 2010 Apr 24.

PMID:
20483162
21.

Clinical evaluation alveolar ridge preservation with a beta-tricalcium phosphate socket graft.

Horowitz RA, Mazor Z, Miller RJ, Krauser J, Prasad HS, Rohrer MD.

Compend Contin Educ Dent. 2009 Nov-Dec;30(9):588-90, 592, 594 passim; quiz 604, 606.

PMID:
19998726
22.

Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.

Gururangan S, Krauser J, Watral MA, Driscoll T, Larrier N, Reardon DA, Rich JN, Quinn JA, Vredenburgh JJ, Desjardins A, McLendon RE, Fuchs H, Kurtzberg J, Friedman HS.

Neuro Oncol. 2008 Oct;10(5):745-51. doi: 10.1215/15228517-2008-044. Epub 2008 Aug 28.

24.

Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors.

Liu G, Lynch JK, Freeman J, Liu B, Xin Z, Zhao H, Serby MD, Kym PR, Suhar TS, Smith HT, Cao N, Yang R, Janis RS, Krauser JA, Cepa SP, Beno DW, Sham HL, Collins CA, Surowy TK, Camp HS.

J Med Chem. 2007 Jun 28;50(13):3086-100. Epub 2007 May 27.

PMID:
17530838
25.

Temozolomide in children with progressive low-grade glioma.

Gururangan S, Fisher MJ, Allen JC, Herndon JE 2nd, Quinn JA, Reardon DA, Vredenburgh JJ, Desjardins A, Phillips PC, Watral MA, Krauser JM, Friedman AH, Friedman HS.

Neuro Oncol. 2007 Apr;9(2):161-8. Epub 2007 Mar 8.

26.

Etiology and management of implant complications. Interview.

Krauser J.

Dent Implantol Update. 2005 Apr;16(4):25-31. No abstract available.

PMID:
15819523
27.
28.

Testosterone 1 beta-hydroxylation by human cytochrome P450 3A4.

Krauser JA, Voehler M, Tseng LH, Schefer AB, Godejohann M, Guengerich FP.

Eur J Biochem. 2004 Oct;271(19):3962-9.

29.

Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2.

Guengerich FP, Krauser JA, Johnson WW.

Biochemistry. 2004 Aug 24;43(33):10775-88.

PMID:
15311939
30.

Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis.

Guengerich FP, Sorrells JL, Schmitt S, Krauser JA, Aryal P, Meijer L.

J Med Chem. 2004 Jun 3;47(12):3236-41.

PMID:
15163202
31.

Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.

Andrieux L, Langouët S, Fautrel A, Ezan F, Krauser JA, Savouret JF, Guengerich FP, Baffet G, Guillouzo A.

Mol Pharmacol. 2004 Apr;65(4):934-43.

PMID:
15044623
32.

Microsomal oxidation of tribromoethylene and reactions of tribromoethylene oxide.

Yoshioka T, Krauser JA, Guengerich FP.

Chem Res Toxicol. 2002 Nov;15(11):1414-20.

PMID:
12437332
33.

Inhibition of arginine gingipains (RgpB and HRgpA) with benzamidine inhibitors: zinc increases inhibitory potency.

Krauser JA, Potempa J, Travis J, Powers JC.

Biol Chem. 2002 Jul-Aug;383(7-8):1193-8.

PMID:
12437105
34.

Tetrachloroethylene oxide: hydrolytic products and reactions with phosphate and lysine.

Yoshioka T, Krauser JA, Guengerich FP.

Chem Res Toxicol. 2002 Aug;15(8):1096-105.

PMID:
12184794
35.

Implant failure.

Callan DP, Hahn J, Hogan B, Jenkins G, Krauser JT.

Implant Dent. 2002;11(2):109-17. No abstract available.

PMID:
12083061
36.

A new view for restorative dentistry. Endoscopic intraoral viewing system.

Silverstein LH, Kurtzman D, Shatz PC, Krauser JT.

Dent Today. 2002 May;21(5):78-83. No abstract available.

PMID:
12026725
38.
40.

Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results.

Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M.

J Periodontol. 2000 Nov;71(11):1671-9. Erratum in: J Periodontol 2001 Apr;72(4):570. J Periodontol. 2001 Apr;72 (4):570.

PMID:
11128913
41.

Fatigue properties of hydroxyapatite-coated dental implants after exposure to a periodontal pathogen.

Mukherjee DP, Dorairaj NR, Mills DK, Graham D, Krauser JT.

J Biomed Mater Res. 2000 Sep;53(5):467-74.

PMID:
10984693
42.

Review of membranes used for guided tissue regeneration.

Krauser J.

Dent Implantol Update. 1998 Oct;9(10):77-80. No abstract available.

PMID:
10530149
43.
44.

A regeneration update: resorbable and non-resorbable membranes.

Krauser JT.

Dent Implantol Update. 1997 Nov;8(11):85-8. No abstract available.

PMID:
9555241
45.

High-density PTFE membranes: uses with root-form implants.

Krauser JT.

Dent Implantol Update. 1996 Sep;7(9):65-9. No abstract available.

PMID:
9525168
46.

When to use resorbable or non-resorbable membranes in concert with root-form implants.

Krauser JT.

Dent Implantol Update. 1995 Apr;6(4):25-9. No abstract available.

PMID:
9525142
47.

Osseointegration in the maxilla: a presentation of three treatment plans.

Krauser JT, Boner N, Boner C, Renner A.

Pract Periodontics Aesthet Dent. 1993 Jun-Jul;5(5):43-4. No abstract available.

PMID:
8219167
48.

HA-coated root-form implants--is there cause for concern?

Lemons JE, Meffert RM, Hahn JA, Krauser JT, James RA.

Dent Implantol Update. 1993 May;4(5):37-42. No abstract available.

PMID:
10530135
49.

Peri-implantitis.

Garg AK, Krauser J, Ortega A.

Implant Soc. 1993;4(3):1, 5-9, 16. No abstract available.

PMID:
8148426
50.

Long-term retrospective studies on hydroxyapatite coated endosteal and subperiosteal implants.

Golec TS, Krauser JT.

Dent Clin North Am. 1992 Jan;36(1):39-65. Review.

PMID:
1310661

Supplemental Content

Loading ...
Support Center